Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

117.94
Delayed Data
As of Feb 27
 +0.80 / +0.68%
Today’s Change
79.62
Today|||52-Week Range
132.95
+4.67%
Year-to-Date
3 Most Wildly Overvalued Stocks in Healthcare
Feb 23 / MotleyFool.com - Paid Partner Content
These 3 Stocks Would Have Tripled Your Money Over the Last 3 Years
Feb 21 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close117.14
Today’s open117.36
Day’s range116.55 - 118.84
Volume716,894
Average volume (3 months)546,312
Market cap$5.1B
Dividend yield--
Data as of 02/27/2017

Growth & Valuation

Earnings growth (last year)-67.92%
Earnings growth (this year)+38.56%
Earnings growth (next 5 years)+25.50%
Revenue growth (last year)+43.09%
P/E ratio110.2
Price/Sales12.92
Price/Book13.53

Competitors

 Today’s
change
Today’s
% change
MASIMasimo Corp+1.66+1.88%
WSTWest Pharmaceutical ...-0.38-0.45%
NUVANuVasive Inc+0.21+0.28%
DXCMDexCom Inc+0.71+0.90%
Data as of 02/27/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)$0.35
Annual revenue (last year)$329.5M
Annual profit (last year)$38.1M
Net profit margin11.58%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts


Search for Jobs